The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fiorentini, S.
Right arrow Articles by Caruso, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fiorentini, S.
Right arrow Articles by Caruso, A.
The Journal of Immunology, 2001, 166: 900-907.
Copyright © 2001 by The American Association of Immunologists

CD11b Expression Identifies CD8+CD28+ T Lymphocytes with Phenotype and Function of Both Naive/Memory and Effector Cells1

Simona Fiorentini*, Stefano Licenziati*, Giulio Alessandri*, Francesco Castelli{dagger}, Silvio Caligaris{dagger}, Monica Bonafede*, Manuela Grassi*, Emirena Garrafa*, Andrea Balsari{ddagger}, Adolfo Turano* and Arnaldo Caruso2,*

* Institute of Microbiology and {dagger} Department of Infectious Diseases, University of Brescia Medical School, Brescia, Italy; and {ddagger} Chair of Immunology, National Cancer Institute, University of Milan, Milan, Italy

A previously unreported CD8+CD28+CD11b+ T cell subset occurs in healthy individuals and expands in patients suffering from primary viral infections. In functional terms, these cells share the features of naive/memory CD8+CD28+CD11b- and terminally differentiated effector CD8+CD28-CD11b+ subpopulations. Like CD28- cells, CD28+CD11b+ lymphocytes have the ability to produce IFN-{gamma}, to express perforin granules in vivo, and to exert a potent cytolytic activity. Moreover, these cells can respond to chemotactic stimuli and can efficiently cross the endothelial barrier. In contrast, like their CD11b- counterpart, they still produce IL-2 and retain the ability to proliferate following mitogenic stimuli. The same CD28+CD11b+ subpopulation detected in vivo could be generated by culturing naive CD28+CD11b- cells in the presence of mitogenic stimuli following the acquisition of a CD45RO+ memory phenotype. Considering both phenotypic and functional properties, we argue that this subset may therefore constitute an intermediate phenotype in the process of CD8+ T cell differentiation and that the CD11b marker expression can distinguish between memory- and effector-type T cells in the human CD8+CD28+ T cell subset.




This article has been cited by other articles:


Home page
Rheumatology (Oxford)Home page
C. Iking-Konert, T. Vogl, B. Prior, C. Wagner, O. Sander, E. Bleck, B. Ostendorf, M. Schneider, K. Andrassy, and G. M. Hansch
T lymphocytes in patients with primary vasculitis: expansion of CD8+ T cells with the propensity to activate polymorphonuclear neutrophils
Rheumatology, May 1, 2008; 47(5): 609 - 616.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
P. Cappello, F. Triebel, M. Iezzi, C. Caorsi, E. Quaglino, P.-L. Lollini, A. Amici, E. Di Carlo, P. Musiani, M. Giovarelli, et al.
LAG-3 Enables DNA Vaccination to Persistently Prevent Mammary Carcinogenesis in HER-2/neu Transgenic BALB/c Mice
Cancer Res., May 15, 2003; 63(10): 2518 - 2525.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
Y.-J. Kim, R. R. Brutkiewicz, and H. E. Broxmeyer
Role of 4-1BB (CD137) in the functional activation of cord blood CD28-CD8+ T cells
Blood, October 16, 2002; 100(9): 3253 - 3260.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. C. G. Marcondes, E. M. E. Burudi, S. Huitron-Resendiz, M. Sanchez-Alavez, D. Watry, M. Zandonatti, S. J. Henriksen, and H. S. Fox
Highly Activated CD8+ T Cells in the Brain Correlate with Early Central Nervous System Dysfunction in Simian Immunodeficiency Virus Infection
J. Immunol., November 1, 2001; 167(9): 5429 - 5438.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.